Mallinckrodt Inc. Painkiller Gets FDA OK
11/2/2009 8:05:31 AM
More...
|
Covidien (COV) Receives FDA Clearance for its Mallinckrodt Inc. TaperGuard Evac Endotracheal Tube
9/30/2009 7:04:19 AM
More...
|
Neuromed Pharmaceuticals Announces Sale of U.S. Rights to Drug Candidate Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) to Mallinckrodt Inc.
6/17/2009 7:26:33 AM
More...
|
Medwatch: Phosphocol P 32 - Risk of Leukemia Associated with Off-label Intra-Articular Use in Children
9/18/2008 12:26:14 PM
More...
|
Covidien Ltd Announces Agreement with Purdue Pharmaceuticals L.P. Enabling Launch of Oxycodone Hydrochloride Extended-Release Tablets
9/2/2008 9:07:52 AM
More...
|
Purdue Pharmaceuticals L.P. Announces Resolution of OxyContin(R) Patent Lawsuit with Mallinckrodt Inc.
9/2/2008 7:49:19 AM
More...
|
Mallinckrodt Launches Magnacet(TM) Tablets
6/7/2007 11:32:45 AM
More...
|
Mallinckrodt Inc. Initiates Voluntary Imaging Product Recall
3/14/2007 11:01:31 AM
More...
|
Ambrilia Biopharma Inc. and Mallinckrodt Announce IND Filing for Phase III Clinical Study of Improved Octreotide Formulation
3/13/2007 10:18:13 AM
More...
|
Mallinckrodt Inc. Signs New Imaging And Radiopharmaceutical Agreements With Premier Purchasing Partners
1/3/2007 12:49:28 PM
More...
|
|